MedPath

TAIWANJ PHARMACEUTICALS, CO., LTD.

TAIWANJ PHARMACEUTICALS, CO., LTD. logo
๐Ÿ‡น๐Ÿ‡ผTaiwan
Ownership
-
Employees
-
Market Cap
-
Website

Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)

Phase 2
Conditions
Autoimmune Hepatitis
Interventions
Other: Placebo
First Posted Date
2020-05-01
Last Posted Date
2020-09-01
Lead Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Target Recruit Count
120
Registration Number
NCT04371718

A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule

Phase 1
Conditions
Autoimmune Hepatitis
Interventions
Drug: JKB-122 in capsule or tablet form
First Posted Date
2020-03-18
Last Posted Date
2020-07-15
Lead Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Target Recruit Count
8
Registration Number
NCT04313205

A Study to Evaluate the Efficacy and Safety of JKB-122 in Patients With NASH and Fibrosis

Phase 2
Conditions
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions
Drug: Placebo
Drug: Dose 1 JKB-122
Drug: Dose 2 JKB-122
First Posted Date
2020-02-05
Last Posted Date
2020-02-13
Lead Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Target Recruit Count
300
Registration Number
NCT04255069

Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies

Phase 2
Completed
Conditions
Autoimmune Hepatitis
Interventions
First Posted Date
2015-09-22
Last Posted Date
2020-07-21
Lead Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Target Recruit Count
20
Registration Number
NCT02556372
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Advanced Liver Therapies, Baylor College of Medicine, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Massachusetts General Hospital, Boston, Massachusetts, United States

๐Ÿ‡บ๐Ÿ‡ธ

Methodist Dallas Medical Center, Dallas, Texas, United States

and more 13 locations

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies

Phase 2
Terminated
Conditions
Chronic Hepatitis C
Interventions
Drug: JKB-122 5mg
Drug: JKB-122 15mg
Drug: JKB-122 35mg
Drug: Placebo
First Posted Date
2014-11-19
Last Posted Date
2020-07-21
Lead Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Target Recruit Count
54
Registration Number
NCT02293941
Locations
๐Ÿ‡จ๐Ÿ‡ณ

Chia-Yi Christian Hospital, Chiayi City, Taiwan

๐Ÿ‡จ๐Ÿ‡ณ

Chang Gung Memorial Hospital, Chiayi, Chiayi City, Taiwan

๐Ÿ‡จ๐Ÿ‡ณ

National Taiwan University Hospital, Taipei, Taiwan

and more 11 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath